XML 15 R4.htm IDEA: XBRL DOCUMENT v3.25.4
Consolidated Balance Sheets - USD ($)
$ in Millions
Dec. 31, 2025
Sep. 30, 2025
Current Assets    
Cash and cash equivalents $ 173.1 $ 164.8
Trade receivables, net 280.7 297.3
Receivables from long-term manufacturing contracts, net 274.7 278.8
Inventories, net 349.4 344.0
Prepaid expenses and other current assets 154.3 156.6
Property, plant, and equipment, net 233.9 238.5
Operating lease right-of-use assets, net 107.8 104.1
Intangible assets, net 1,116.9 1,136.0
Goodwill 1,607.5 1,601.4
Equity method investments 108.1 76.4
Total Assets 4,469.1 4,467.1
Current Liabilities    
Trade accounts payable 342.5 364.4
Liabilities from long-term manufacturing contracts and advances 238.9 241.9
Current portion of long-term debt 22.9 22.8
Accrued compensation 83.2 109.0
Other current liabilities 279.0 282.6
Long-term debt 1,556.1 1,502.0
Accrued pension and postretirement healthcare 81.7 82.5
Operating lease liabilities 80.4 77.1
Deferred income taxes 196.6 190.0
Other long-term liabilities 167.6 170.6
Commitments and contingencies (Note 13)
SHAREHOLDERS’ EQUITY    
Common stock, no par value (75.8 and 75.8 shares issued, 70.7 and 70.2 shares outstanding) 0.0 0.0
Additional paid-in capital 713.5 717.9
Retained earnings 1,005.4 1,024.0
Treasury stock (5100000 and 5300000 shares, at cost) (220.0) (227.1)
Accumulated other comprehensive loss (117.8) (128.1)
Noncontrolling interests 39.1 37.5
Total Shareholders’ Equity 1,420.2 1,424.2
Equity Method Investments $ 62.7 $ 69.2